Archive 2001
News  | | Date |
Eurogentec has been awarded "Belgium's entrepreneur of the Year 2001"
Eurogentec has been proclaimed "Belgium's entrepreneur of the Year 2001" by the Belgian Federal Minister of Finance, Didier Reynders. Jean-Pierre Delwart (CEO) and Joseph Martial (Chairman of the Board of Directors) accepted this prestigious award during this year's event in Brussels. read more >>
|
|
November 2001
|
Eurogentec completes an EURO 5 million round of financing aiming at fuelling its expansion strategy
EUROGENTEC announced today that it has successfully increased its capital through a private placement of EURO 5 million subscribed by existing shareholders and new investors. This new cash injection will help the company to deploy its growth strategy internationally. read more >>
|
|
September 2001
|
Eurogentec: doubling of operating result in 2000/2001
Turnover up by 17.4 % even better than the objective set at the beginning of the financial year read more >>
|
|
July 2001
|
With the creation of Nippon EGT, Eurogentec is moving into Japan, the fastest growing biotech market
Eurogentec, BMI-SBI and Nippon Gene Co., ltd. are announcing the creation of a joint venture, Nippon EGT, whose mission will be to produce oligonucleotides aimed at the Japanese market. Nippon EGT will benefit from all the know-how developed by Eurogentec, and will have priority access to the Nippon Gene distribution network. The Japanese market is currently growing at a rate of around 30% a year, a growth which is greater than that seen on the European and American markets. read more >>
|
|
July 2001
|
Research Applications at Eurogentec greatly enhanced due to Roche's licence of PCR Technology
Eurogentec, has announced today that it has signed with F. Hoffmann-La Roche, Basel, Switzerland ("FHLR") and Roche Molecular Systems, Inc., Pleasanton, CA, USA ("RMS" ) (jointly known as "Roche") a non-exclusive, worldwide license agreement relating to the manufacture of DNA polymerase enzymes and kits containing enzymes for use with PCR-based applications in the life sciences market. read more >>
|
|
February 2001
|
Back to news list
|